AbbVie Inc.ABBVNYSE
Loading
Income Before Tax Over TimeStable
Percentile Rank57
3Y CAGR-21.2%
5Y CAGR+14.2%
Year-over-Year Change
Pre-tax earnings
3Y CAGR
-21.2%/yr
vs +26.9%/yr prior
5Y CAGR
+14.2%/yr
Recent deceleration
Acceleration
-48.1pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $6.60B | +77.5% |
| 2024 | $3.72B | -40.5% |
| 2023 | $6.25B | -53.6% |
| 2022 | $13.48B | +3.8% |
| 2021 | $12.99B | +282.3% |
| 2020 | $3.40B | -59.7% |
| 2019 | $8.43B | +62.1% |
| 2018 | $5.20B | -32.7% |
| 2017 | $7.73B | -2.0% |
| 2016 | $7.88B | - |